SHARE PRICE
Get to know the company overview of SYNGENE - face value, book value, exchange symbol, 1 year & lifetime highs/lows, average volume, market cap, PE ratio, 1 month return, % promoter holding pledged before investing in SYNGENE
| Current Price (Rs.) | 308.70 |
| Face Value (Rs.) | 10 |
| Book Value (Rs.) | 49.21 |
| 52 Week High (Rs.) | 369.00 (14-Jun-19) |
| 52 Week Low (Rs.) | 250.05 (14-Dec-18) |
| Life Time high (Rs.) | 369.00 (14-Jun-19) |
| Life Time low (Rs.) | 147.50 (11-Aug-15) |
| Exchange Symbol | SYNGENE (NSE) |
| Average Daily Movement [ADM] | 9.17 |
| Average Volume [20 days](No. of shares) | 169480 |
| Market Cap (Rs. in Cr) | 12348.00 (Cr) |
| 1 Month Return (%) | -6.63 |
| P/E Ratio (x) | 31.86 |
| % of Promoter holding pledged | 0.00 |
SHARE PRICE CHART
We recommend to use only Weekly and Monthly charts. Daily charts are also given which are used for exits.
We do not recommend daily/intraday minute hourly charts.
Why should you follow Weekly & Monthly levels - The major levels come from weekly and monthly charts which the FII, fund managers usually use for entry and profit booking.
SYNGENE, NSE, INDIA
QUARTERLY RESULTS
| Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | |
| Quarterly | Quarterly | Quarterly | Quarterly | Quarterly | Quarterly | |
| Source Of Info (AR = Annual Report, PR = Press Release) | ||||||
| Net Sales/Income from operations | ||||||
| Other Operating Income | ||||||
| Total Income From Operations | ||||||
| Increase/Decrease in Stocks | ||||||
| Consumption of Raw Materials | ||||||
| Employees Cost | ||||||
| Depreciation | ||||||
| Other Expenses | ||||||
| Total Expenditure | ||||||
| Operating Profit | ||||||
| Other Income | ||||||
| P/L Before Int., Excpt. Items & Tax | ||||||
| Interest | ||||||
| P/L Before Exceptional Items & Tax | ||||||
| Exceptional Item | ||||||
| P/L Before Tax | ||||||
| Tax | ||||||
| P/L After Tax from Ordinary Activities | ||||||
| PAT | ||||||
| Net Profit/(Loss) For the Period | ||||||
| Equity Share Capital | ||||||
| Reserves | ||||||
| Equity Dividend Rate (%) | ||||||
| EPS (Rs.) [After Extraordinary items] | ||||||
| EPS (Rs.) [Before Extraordinary items] |
RATIO ANALYSIS
Among all the ratios these are the most important ratios to look before investing in a company.
Get the latest key Financial Ratios and the Ratio Analysis of to gauge the overall financial health of a company before investing.
| Name | Ratio | Good/Not Good | Description |
| Current Ratio (x) | 1.13 | > 2 is Good, < 2 is Not Good |
A liquidity ratio that measures a companys ability to pay short-term obligations. The higher the current ratio, the more capable the company is of paying its obligations. |
| Quick Ratio (x) | 1.02 | > 1 is Good, < 1 is Not Good |
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets |
| Dividend Yield (%) | 0.16 | > 1.5 is Good, < 1.5 is Not Good |
A financial ratio that shows how much a company pays out in dividends each year relative to its share price. Dividend yield is calculated as annual dividends per share divided by market price per share. |
| Interest Coverage Ratio (x) | 18.94 | > 2 is Good, < 2 is Not Good (For Banks & NBFC this is not Valid) |
It is used to determine how easily a company can pay interest on outstanding debt. It is calculated by dividing a companys EBIT by the interest expenses. |
| Debt Equity Ratio (x) | 0.28 | < 2 is Good, > 2 is Not Good (For Banks & NBFC this is not Valid) |
A measure of a companys financial leverage calculated by dividing its total liabilities by stockholders equity. The debt/equity ratio also depends on the industry in which the company operates. |
| Return On Asset (%) | 13.07 | > 5% is Good, < 5% is Not Good |
An indicator of how efficient management is at using its assets to generate earnings. Calculated by dividing a companys annual earnings by its total assets |
| Return On Equity (%) | 16.84 | > 18% is Good, < 18% is Not Good |
Also called Return on networth, it measures a companys profitability by revealing how much profit a company generates with the money shareholders have invested, it is calculated by dividing the net profit after tax by shareholder's fund For high growth companies you should expect a higher ROE. |
For investors interested in SYNGENE find all important information on SYNGENE share price, peer comparison and analysis.
DIVIDEND
Get a glimpse into the dividend history-payout amount of SYNGENE, interim dividend and the latest dividend announcements by SYNGENE in the last 5 years.
| # | Announcement Date | Ex-Date | Amount | Interim/Final |
|---|---|---|---|---|
| 1 | 24-Apr-2019 | 16-Jul-2019 | 0.50 | Final |
| 2 | 25-Apr-2018 | 17-Jul-2018 | 1.00 | Final |
| 3 | 02-May-2017 | 20-Jul-2017 | 1.00 | Final |
| 4 | 08-Mar-2016 | 17-Mar-2016 | 1.00 | Interim |
PROMOTER SHAREHOLDING
Look up all relevant information on shareholding pattern of SYNGENE, the change in shareholding as compared to last quarter, Promoters shareholding%, persons holding more than 1% shares of the company.
| Shareholding Pattern | Sep-19 | Jun-19 | Jun-19 | Jun-19 | Mar-19 |
| Promoter and Promoter Group (%) | 70.77 | 71.03 | 71.04 | 71.04 | 71.05 |
| Indian | 70.77 | 71.03 | 71.04 | 71.04 | 71.05 |
| Foreign | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Institutions (%) | 22.80 | 22.23 | 22.29 | 22.29 | 22.10 |
| FII | 15.39 | 15.68 | 15.82 | 15.82 | 16.51 |
| DII | 7.42 | 6.55 | 6.47 | 6.47 | 5.58 |
| NonInstitutions (%) | 6.42 | 6.74 | 6.67 | 6.67 | 6.85 |
| Bodies Corporate | NIL | NIL | NIL | NIL | NIL |
| Others | 5.49 | 5.75 | 5.69 | 5.69 | 5.83 |
| Custodians | 0.94 | 0.99 | 0.99 | 0.99 | 1.02 |
| Total no. of shares (cr.) | 40.00 | 40.00 | 40.00 | 20.00 | 20.00 |
PUBLIC SHAREHOLDING
Study of the shareholding pattern of a company is a very important part of fundamental analysis. The shareholding pattern is a determinant of the market capitalization of the stock and is an indicator of whether the stock valuation is justified or not. Know the Public shareholding % for the last quarter as announced by the company.
| Persons holding securities more than 1% of total number of shares under category Public Shareholding. | Category | Dec-16 | Sep-16 | Mar-16 | Dec-15 | Mar-17 |
| BIOCON LIMITED | Promoters | 72.61 | NIL | 72.61 | NIL | 72.61 |
| SILVER LEAF OAK (MAURITIUS) LIMITED | NonPromoters | 7.20 | 9.63 | 9.93 | NIL | 7.20 |
| STEADVIEW CAPITAL MAURITIUS LIMITED | NonPromoters | 1.50 | NIL | NIL | NIL | 1.50 |
| Biocon Limited | Promoters | NIL | 72.61 | NIL | 72.61 | NIL |
| CANARA HSBC ORIENTAL BANK OF COMMERCE LIFE INSURANCE COMPANY LTD | NonPromoters | NIL | 1.01 | NIL | NIL | NIL |
| GOLDMAN SACHS INDIA FUND LIMITED | NonPromoters | NIL | NIL | 1.09 | NIL | NIL |
| Foreign Corporate Bodies | NonPromoters | NIL | NIL | NIL | 9.93 | NIL |
| Silver Leaf Oak (Mauritius) Limited | NonPromoters | NIL | NIL | NIL | 9.93 | NIL |
| Bodies Corporate | NonPromoters | NIL | NIL | NIL | 1.78 | NIL |
| Goldman Sachs India Fund Limited | NonPromoters | NIL | NIL | NIL | 1.09 | NIL |
COMPANY PROFILE
Study SYNGENE management, company profile, ownership, management, Board of Directors and Organization Structure of SYNGENE
| COMPANY PROFILE OF SYNGENE, NSE, INDIA | |
|---|---|
| Date of Incorporation | 18-Nov-1993 |
| Date of Listing | 11-Aug-2015 |
| Management | |
| Name | Designation |
| Vinita Bali | Addnl.Independent Director |
| Bala S Manian | Independent Director |
| Suresh Talwar | Independent Director |
| Russell Walls | Independent Director |
| Paul Blackburn | Independent Director |
| Vijay Kuchroo | Independent Director |
| Kiran Mazumdar Shaw | Managing Director |
| John Shaw | Non Executive Director |
| Catherine Rosenberg | Non Executive Director |
| Jonathan Hunt | WholeTime Director & CFO |
| Registered Office Address | |
| Biocon SEZ, Biocon Park, Plant No.2 & 3, Bommasandra Industrial Area,IV Phase, Jigani Link Road,, 560099, Bengaluru, Karnataka, India, | |
| Website | |
| http://www.syngeneintl.com | |
PEERS PRICE COMPARISION
| # | Company Name | Open | High | Low | Last Price | Prv Price | Change | % Chng |
|---|---|---|---|---|---|---|---|---|
| 1 | SYNGENE | 495.10 | 503.65 | 491.00 | 493.95 | 493.95 | 0 | 0.00 |
| 2 | MARKSANS PHARMA | 45.50 | 46.20 | 44.75 | 45.25 | 45.25 | 0 | 0.00 |
| 3 | SHILPA MEDICARE | 659.50 | 663.90 | 645.25 | 656.85 | 656.85 | 0 | 0.00 |
| 4 | PROCTER GAMBLE HEALTH | 1015.50 | 1072.00 | 1015.50 | 1064.30 | 1064.30 | 0 | 0.00 |
| 5 | OPTO CIRCUITS | 6.95 | 7.00 | 6.90 | 6.95 | 6.95 | 0 | 0.00 |
| 6 | ALEMBIC PHARMA | 500.00 | 501.70 | 497.00 | 500.30 | 500.30 | 0 | 0.00 |
| 7 | IPCA | 500.00 | 503.45 | 493.00 | 495.55 | 495.55 | 0 | 0.00 |
| 8 | KOPRAN | 71.30 | 72.00 | 70.50 | 70.90 | 70.90 | 0 | 0.00 |
| 9 | RPG LIFE | 387.55 | 405.00 | 387.55 | 396.80 | 396.80 | 0 | 0.00 |
| 10 | CAPLIN POINT | 700.40 | 707.50 | 690.20 | 697.90 | 697.90 | 0 | 0.00 |
| 11 | NECTAR LIFESCIENCES | 27.65 | 27.65 | 26.95 | 27.20 | 27.20 | 0 | 0.00 |
| 12 | SPARC | 370.40 | 374.80 | 365.50 | 367.85 | 367.85 | 0 | 0.00 |
| 13 | FDC | 183.10 | 188.10 | 183.10 | 186.75 | 186.75 | 0 | 0.00 |
| 14 | PFIZER | 1728.80 | 1730.05 | 1711.00 | 1717.15 | 1717.15 | 0 | 0.00 |
| 15 | BROOKS LAB | 107.00 | 112.50 | 107.00 | 108.80 | 108.80 | 0 | 0.00 |
| 16 | VIMTA LABS | 128.40 | 130.40 | 128.40 | 129.00 | 129.00 | 0 | 0.00 |
| 17 | JB CHEMICALS | 280.25 | 283.15 | 275.00 | 275.90 | 275.90 | 0 | 0.00 |
| 18 | MOREPEN LAB | 16.75 | 17.00 | 16.50 | 16.60 | 16.60 | 0 | 0.00 |
| 19 | SANOFI INDIA | 4208.95 | 4230.00 | 4200.00 | 4213.30 | 4213.30 | 0 | 0.00 |
| 20 | DISHMAN | 288.20 | 304.20 | 278.00 | 301.20 | 301.20 | 0 | 0.00 |
| 21 | NATCO PHARMA | 995.95 | 995.95 | 983.00 | 986.70 | 986.70 | 0 | 0.00 |
| 22 | ALKEM LABORATORIES | 1841.00 | 1843.00 | 1821.00 | 1825.00 | 1825.00 | 0 | 0.00 |
| 23 | SUVEN | 222.05 | 230.40 | 218.10 | 221.15 | 221.15 | 0 | 0.00 |
| 24 | GLAXO PHARMA | 2464.00 | 2474.00 | 2436.30 | 2451.80 | 2451.80 | 0 | 0.00 |
| 25 | PIRAMAL ENTERPRISES | 2746.00 | 2774.90 | 2725.25 | 2761.50 | 2761.50 | 0 | 0.00 |
| 26 | BLISS GVS | 175.00 | 178.90 | 168.60 | 176.85 | 176.85 | 0 | 0.00 |
| 27 | VENUS REMEDIES | 104.05 | 104.15 | 103.00 | 103.50 | 103.50 | 0 | 0.00 |
| 28 | JUBILANT | 657.60 | 662.85 | 641.60 | 643.70 | 643.70 | 0 | 0.00 |
